Table 4.

Results of the cost-effectiveness analysis

		Predicted mortality
Cost-effectiveness analysis	ALL patients	< 5%	5% to 40%	> 40%
Cost per life saved	103,771 (56,855 to 150,687)	-197,195 (-3,635,418 to 3,241,028)	117,675 (36,241 to 199,109)	60,046 (24,521 to 95,571)
Cost per life-year saved	7,065 (3,871 to 10,259)	-13,426 (-247,510 to 220,658)	8,012 (2,467 to 13,556)	4,088 (1,669 to 6,507)

Estimates of mortality adjusted as in Table 3, and estimates of costs adjusted for the same variables. Reported are costs in $, with 95% CI